NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-183-2009-0-CH-09 Schweinfurthins And Uses Thereof CH EP 10719562.0 Issued
NCI E-183-2009-0-ES-11 Schweinfurthins And Uses Thereof ES EP 10719562.0 Issued
NCI E-183-2009-0-AU-04 Schweinfurthin And Uses Thereof AU National Stage 2010242874 Abandoned
NCI E-159-2009-1-PCT-01 LAT2KR For Adoptive Immunotherapy PCT PCT COMB PCT/US2010/033186 Expired
NCI E-183-2009-0-PCT-02 Schweinfurthin And Uses Thereof PCT PCT PCT/US2010/033153 Expired
NIAID E-160-2010-0-US-01 Inhibition Of The Cellular Kinase, DNA Dependent Protein Kinase (DNA-PK), As ATherapeutic Intervention For HIV Infection US 61/329,775 Abandoned
NIDA E-076-2016-0-US-03 TLR MODULATORS AND METHODS FOR USING THE SAME US National Stage 12/740,690 Abandoned
NCATS E-120-2010-0-US-01 Activators Of Human Pyruvate Kinase US 61/329,158 Abandoned
NIAID E-323-2005-2-US-08 INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS US DIV 12/769,304 8765136 Abandoned PDF
NCATS E-041-2010-0-US-01 Small Molecule Neuropeptide S (NPS) Antagonists For The Treatment Of Addictive Disorders, Mood And Anxiety Disorders And Sleep Disorders US 61/328,900 Abandoned
NCI E-200-2010-0-US-01 Therapies Using Zanolimumab To Enhance The Immune Response US 61/328,896 Abandoned
NCI E-181-2006-0-IT-24 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer IT EP 12165740.7 Abandoned
NCI E-181-2006-0-FR-23 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer FR EP 12165740.7 Abandoned
NCI E-181-2006-0-ES-22 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer ES EP 12165740.7 Abandoned
NCI E-174-2010-0-DK-01 Diagnosing And Treating Fibrotic Diseases Using MicroRNA-17 DK ORD PA 2010 00362 Abandoned
NCI E-097-2009-0-DE-07 Anti-human ROR1 Antibodies DE EP 10715077.3 Issued
NCI E-097-2009-0-FR-08 Anti-human ROR1 Antibodies FR EP 10715077.3 Issued
NCI E-097-2009-0-GB-09 Anti-human ROR1 Antibodies GB EP 10715077.3 Issued
NCI E-097-2009-0-EP-03 Anti-human ROR1 Antibodies EP National Stage 10715077.3 Issued
NHLBI E-114-2004-0-US-09 A Method of Treating Or Inhibiting Inflammation by Multi-Domain Amphipathic Helical Peptides US CON 12/766,761 8148323 Expired PDF
NHLBI E-337-2008-0-PCT-02 STENT FOR VALVE REPLACEMENT PCT PCT PCT/US2010/032257 Expired
NCI E-097-2009-0-PCT-02 Anti-human ROR1Antibodies MAb 2A2 PCT PCT PCT/US2010/032208 Expired
NHLBI E-337-2008-0-EP-04 Self-expanding Stent For Aortic Valve Replacement EP National Stage 10767845.0 Abandoned
NIEHS E-180-2011-0-US-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A GENETIC PREDISPOSITION TO PARKINSON DISEASE US 61/327,508 Abandoned
NCI E-097-2009-0-AU-05 Anti-human ROR1Antibodies AU National Stage 2010238723 Abandoned
NCI E-170-2009-0-DE-07 Inducible Interleukin-12 DE EP 10717361.9 Issued
NCI E-170-2009-0-FR-08 Inducible Interleukin-12 FR EP 10717361.9 Issued
NCI E-170-2009-0-GB-09 Inducible Interleukin-12 GB EP 10717361.9 Issued
NCI E-170-2009-0-EP-05 Inducible Interleukin-12 EP National Stage 10717361.9 Issued
NCI E-170-2009-0-AU-03 Inducible Interleukin-12 AU National Stage 2010241864 Issued
NCI E-170-2009-0-US-06 Inducible Interleukin-12 US National Stage 13/266,280 8556882 Issued PDF
NCI E-170-2009-0-PCT-02 Inducible Interleukin-12 PCT PCT PCT/US2010/031988 Expired
NCI E-215-2007-0-US-05 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells US National Stage 12/663,586 8465917 Issued PDF
NIAID E-102-2010-0-US-03 Sound Attenuation Canopy US CON 13/303,063 8316986 Issued PDF
NIAID E-102-2010-0-US-01 Sound Attenuation Canopy US ORD 12/764,872 8069947 Issued PDF
NCI E-274-2009-0-US-02 METHODS FOR DETERMINING PRENATAL ALCOHOL EXPOSURE US ORD 12/763,789 Abandoned
NCI E-042-2009-0-US-07 IMMUNOGENIC EPITOPES OF NGEP ANTIGEN US National Stage 13/265,490 8748390 Abandoned PDF
NCI E-042-2009-0-PCT-02 Immunogenic Epilopes of NGEP (new Gene Expressed In Prostate) Antigen PCT PCT PCT/US10/31584 Expired
NCI E-042-2009-0-EP-05 Immunogenic Epitopes of NGEP Antigen EP National Stage 10714428.9 Abandoned
NCI E-042-2009-0-JP-06 Immunogenic Epilopes of NGEP Antigen JP National Stage 2012-507289 Abandoned
NCI E-042-2009-0-AU-03 Immunogenic Epilopes of NGEP Antigen AU National Stage 2010239478 Abandoned
NCI E-042-2009-0-CA-04 Immunogenic Epilopes of NGEP (new Gene Expressed In Prostate) Antigen CA National Stage 2759425 Abandoned
NIEHS E-180-2011-2-US-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A GENETIC PREDISPOSITION TO PARKINSON DISEASE US 61/325,582 Abandoned
NCI E-150-2010-0-US-01 Additional SNPs Associated With Renal Disease US 61/325,343 Abandoned
NCI E-184-2009-0-HK-10 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS HK National Stage 12105197.6 Issued
NCI E-184-2009-0-IE-19 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS IE EP 10715632.5 Issued
NCI E-184-2009-0-DE-15 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS DE EP 10715632.5 Issued
NCI E-184-2009-0-FR-17 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS FR EP 10715632.5 Issued
NCI E-184-2009-0-ES-16 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS ES EP 10715632.5 Issued
NCI E-184-2009-0-CH-14 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS CH EP 10715632.5 Issued